News – Page 1085 – Endpoints News

Hunting for early-stage life sciences bets, Partners Healthcare closes $171M for venture fund

8 years ago

Prepping PhIII for Soliris rival, Apellis rides a boisterous market to a $150M IPO

8 years ago

Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris

8 years ago

Sanofi bolsters its position on multiple sclerosis with a $765M BTK licensing deal

8 years ago

On the heels of a setback, Sage reports PhIII success in postpartum depression -- but questions linger

8 years ago

Eyeing Duchenne MD cure, The Column Group gambles $40M on CRISPR/Cas9 startup Exonics

8 years ago

Surprise: Did Otonomy bring its lead ear drug back from the dead?

8 years ago

Exodus of Ex-Googlers at Silicon Valley's sexiest biotech startups

8 years ago

Boehringer strikes €307M collaboration deal with MiNA; Tricida banks $57.5M venture round for PhIII

8 years ago

Kerrisdale’s Sahm Adrangi leads a brutal new biotech short attack as trial results loom

8 years ago

German biotech InflaRx raises $100M in IPO

8 years ago

Struggling GSK recruits cancer drug guru Hal Barron as its new R&D chief

8 years ago

Amgen bets on stem cell company Fortuna Fix in $25M round

8 years ago

OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch

8 years ago

Who are the top 10 players that dominate the cancer drug market? And who's growing fastest?

8 years ago

An early SITC loser: Five Prime shares crushed as analysts fret over a snapshot on lead drug data

8 years ago

How much is your vision worth? Spark CEO Jeff Marrazzo has a price in mind

8 years ago

Mumbai-based Lupin gets FDA warning for two manufacturing sites; Ionis promotes inotersen head as new COO

8 years ago

Upstart Oyster Point has big plans for disrupting the ophthalmology space, but you'll have to wait for the details

8 years ago

Boasting in-license distribution model, Chinese EOC Pharma bags $32M series B funding for oncology products

8 years ago

FDA gives Cellectis a green light to relaunch off-the-shelf CAR-T studies — with several strings attached

8 years ago

Watch out Sanofi: Takeda's new data on dengue vaccine is good news for PhIII trial

8 years ago

Japanese CMO Fujifilm Diosynth spends extra $28M in US, UK mAb facilities

8 years ago

The Department of Defense could undermine FDA, giving the green light for experimental products

8 years ago

First page Previous page 1082 1083 108410851086 1087 1088 Next page Last page